PATENT CLAIM ANALYSIS

Application Number: 15980411
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["424", "172100"]

Abstract:
Anti-BAFFR antibodies are formulated as liquid formulation comprising a high concentration of the antibody active ingredient for delivery to a patient without high levels of antibody aggregation. The aqueous pharmaceutical composition may include one or more sugars, a buffering agent, a surfactant, and/or a free amino acid.

Claim (Index 6):
The method of  claim 5 , wherein the mammal is human.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 93.0
- Lexical Diversity: 1.2381
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14942388', '13912355', '13991984', '15881195', '13119784']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7650888662810332
- 35 USC 102 Novelty (BERT): 0.5387220993807266
- Combined Prediction Score: 0.7424521895910026
- Mean Citation Score: 302.3662739999998
- Max Citation Score: 389.15375
- Similarity Product: 224.2845320118964

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test